NeoGenomics, Inc. (NEO)
16.54
-0.71
(-4.12%)
USD |
NASDAQ |
Oct 16, 15:16
NeoGenomics SG&A Expense (TTM) : 359.09M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 359.09M |
| March 31, 2026 | 364.02M |
| December 31, 2025 | 365.34M |
| September 30, 2025 | 364.37M |
| June 30, 2025 | 360.08M |
| March 31, 2025 | 349.26M |
| December 31, 2024 | 344.39M |
| September 30, 2024 | 336.24M |
| June 30, 2024 | 327.95M |
| March 31, 2024 | 322.15M |
| December 31, 2023 | 313.94M |
| September 30, 2023 | 311.11M |
| June 30, 2023 | 313.10M |
| March 31, 2023 | 308.92M |
| December 31, 2022 | 313.66M |
| September 30, 2022 | 316.97M |
| June 30, 2022 | 315.42M |
| March 31, 2022 | 312.26M |
| December 31, 2021 | 283.94M |
| September 30, 2021 | 255.44M |
| June 30, 2021 | 223.33M |
| March 31, 2021 | 196.28M |
| December 31, 2020 | 191.66M |
| September 30, 2020 | 187.36M |
| June 30, 2020 | 184.49M |
| Date | Value |
|---|---|
| March 31, 2020 | 181.59M |
| December 31, 2019 | 175.34M |
| September 30, 2019 | 163.58M |
| June 30, 2019 | 146.98M |
| March 31, 2019 | 133.74M |
| December 31, 2018 | 114.22M |
| September 30, 2018 | 102.96M |
| June 30, 2018 | 99.64M |
| March 31, 2018 | 95.54M |
| December 31, 2017 | 94.36M |
| September 30, 2017 | 97.66M |
| June 30, 2017 | 98.01M |
| March 31, 2017 | 98.55M |
| December 31, 2016 | 99.69M |
| September 30, 2016 | 89.48M |
| June 30, 2016 | 74.68M |
| March 31, 2016 | 59.56M |
| December 31, 2015 | 45.19M |
| September 30, 2015 | 39.34M |
| June 30, 2015 | 38.51M |
| March 31, 2015 | 37.56M |
| December 31, 2014 | 35.81M |
| September 30, 2014 | 33.38M |
| June 30, 2014 | 30.70M |
| March 31, 2014 | 27.70M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Precipio, Inc. | 13.54M |
| Quest Diagnostics, Inc. | 2.038B |
| Labcorp Holdings, Inc. | 2.219B |
| OPKO Health, Inc. | 205.85M |
| Psychemedics Corp. | -- |